Milton Street Capital Forms IC Biomedical by Acquiring Worthington Life Sciences Business and International Cryogenics

November 2, 2020

Milton Street Capital, a Houston-based private equity firm, acquired the Life Sciences business of Worthington Industries (Theodore, AL) and International Cryogenics, Inc. (Indianapolis, IN) and combined them to form IC Biomedical. The new company will be led by Steve Shaw (CEO) and Jim Hoppel (CFO) and will focus on manufacturing cryogenic storage freezers, dewars and shippers for biomedical, pharmaceutical and research markets.

Buyers
Milton Street Capital
Targets
Life Sciences business of Worthington Industries, International Cryogenics, Inc.
Sellers
Worthington Industries
Platforms
IC Biomedical
Industry
Medical Devices
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.